The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Business

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management. 

Previous post Biden administration to cancel $6.1 billion in student debt for borrowers who were scammed by single school
Next post CVS posts big earnings miss, cuts profit outlook on higher medical costs

More Stories